What type of study is this?

This is a Network Meta-Analysis study (also classified as: RCT).

Mechanical Circulatory Support Devices versus Standard Medical Therapy for Treatment of Myocardial Infarction Complicated by Cardiogenic Shock: a Network Meta-Analysis

View Full Paper

Ask AI

Bookmark

Authors

Network meta-analysis demonstrates Impella reduces mortality in cardiogenic shock, suggesting effective management strategy.

Impella shows a significant reduction in 6-12 month mortality compared to standard therapy, indicating its potential benefit in treatment.
Eighteen RCTs analyzed revealed Impella increased risk of renal replacement therapy and major bleeding, highlighting safety concerns.
This network meta-analysis exclusively assessed RCTs, focusing on outcomes associated with various mechanical support devices.
Findings suggest further evaluation is essential to balance benefit and morbidity associated with mechanical circulatory support devices.

Freer et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark